Latest News about NASDAQ:IMUX
Recent news which mentions NASDAQ:IMUX
Tags
NASDAQ:IMUX
From News Direct
Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day
May 20, 2024
Tickers
IMUX
Tags
NASDAQ:IMUX
From News Direct
Immunic CEO Dr Daniel Vitt marks International Day of Immunology with discussion on its crucial role
April 29, 2024
Tags
NASDAQ:IMUX
From News Direct
Tags
NASDAQ:IMUX
From News Direct
Immunic to reveal promising MS treatment data in two poster presentations at ACTRIMS Forum 2024
March 08, 2024
Tags
NASDAQ:IMUX
From News Direct
Immunic reports successful 2023 and prepares for key 2025 milestones
February 22, 2024
Tags
NASDAQ:IMUX
From News Direct
Immunic focusing on business development during Q4
November 14, 2023
Tags
NASDAQ:IMUX
From News Direct
Immunic CSO hails "great" progress with MS program
October 24, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From News Direct
Immunic "super excited" about latest PMS trial data
October 11, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From News Direct
Immunic CEO says Q2 results "couldn't be better"
August 07, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From News Direct
Immunic Therapeutics shares IMU-856 mode of action and target for gastrointestinal diseases
June 26, 2023
Tags
NASDAQ:IMUX
From News Direct
Immunic ultimately hoping to "offer patients a new kind of treatment" for multiple sclerosis
May 31, 2023
Tags
NASDAQ:IMUX
From News Direct
Immunic says preclinical data for vidofludimus calcium is a milestone for its lead MS program
May 17, 2023
Tags
NASDAQ:IMUX
From News Direct
Immunic gets a "positive surprise" from lead asset trial
April 13, 2023
Tickers
IMUX
Tags
NASDAQ:IMUX
From News Direct
2 Biotech Stocks to Take off Your Watchlist in 2022
October 19, 2022
From StockNews.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.